aminophenazone

Metabolite details

Identifier

RMMXTBMQSGEXHJ-UHFFFAOYSA-N

InChI Key

RMMXTBMQSGEXHJ-UHFFFAOYSA-N

IUPAC name

4-(dimethylamino)-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one

Preferred name

aminophenazone

INN name

aminophenazonum

Synonym

4-(Dimethylamino)-1,2-dihydro-1,5-dimethyl-2-phenyl-3H-pyrazol-3-one

ChEBI

CHEBI:160246

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• Transcriptomics and metabolomics of engineered Synechococcus elongatus during photomixotrophic growth
• PatA mediates biofilm formation and drugs resistance through regulating the synthesis of glycolipids and lipids in mycobacterium PatA mediates a novel mycolic acid synthesis pathway and regulates biofilm formation in mycobacterium

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• Control_vs_nsPEF_7_day
• Wild_Type_vs_YQ2-gal
• wild_type_vs_patA_deletion